Health Care·Pharmaceuticals·$49.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.90 | N/A | +5.27% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.90 | N/A | +5.27% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a positive outlook regarding their earnings performance. However, they did not provide specific guidance for future quarters.
Management expressed satisfaction with the EPS performance despite not providing revenue figures.
They emphasized their commitment to innovation in animal health.
The earnings report indicates that Zoetis Inc performed better than expected in terms of EPS, which contributed to a significant stock increase of 7.64%. Investors reacted positively to the earnings surprise, suggesting confidence in the company's ongoing performance. However, the lack of revenue data and guidance may leave some investors cautious about future growth prospects.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
MARRIOTT INTL INC NE Class A
Aug 5, 2019